GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fusion Antibodies PLC (LSE:FAB) » Definitions » Price-to-Funds-From-Operations

Fusion Antibodies (LSE:FAB) Price-to-Funds-From-Operations : (As of Jan. 18, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Fusion Antibodies Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Fusion Antibodies Business Description

Traded in Other Exchanges
N/A
Address
1 Springbank Road, Springbank Industrial Estate, Dunmurry, Belfast, GBR, BT17 0QL
Fusion Antibodies PLC offers various antibody engineering services for all therapeutic and diagnostic antibody development stages. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly in cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.